共 139 条
[1]
Conroy S(2000)Survey of unlicensed and off label drug use in paediatric wards in European countries European Network for Drug Investigation in Children. BMJ 320 79-82
[2]
Choonara I(2008)Regulating off-label drug use-rethinking the role of the FDA N Engl J Med 358 1427-1429
[3]
Impicciatore P(2009)Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature J Clin Pharm Ther 34 277-287
[4]
Mohn A(2003)Unlicensed and off-label uses of drugs in paediatrics: a review of the literature Fundam Clin Pharmacol 17 125-131
[5]
Arnell H(2002)Unlicensed and off-label drug use in children: implications for safety Drug Saf 25 1-5
[6]
Rane A(2013)Pediatric off-label drug use in China: risk factors and management strategies J Evid Based Med 6 4-18
[7]
Stafford RS(2011)Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care-a nationwide study Acta Paediatr 100 1272-1275
[8]
Lindell-Osuagwu L(2007)Stimulation programs for pediatric drug research-do children really benefit? Eur J Pediatr 166 849-855
[9]
Korhonen MJ(2007)Off-label drug use in hospitalized children Arch Pediatr Adolesc Med 161 282-290
[10]
Saano S(2014)Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study Acta Paediatr 103 e3-e4